Shai Erlich

1.5k total citations
16 papers, 1.2k citations indexed

About

Shai Erlich is a scholar working on Molecular Biology, Hematology and Physiology. According to data from OpenAlex, Shai Erlich has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Hematology and 5 papers in Physiology. Recurrent topics in Shai Erlich's work include Autoimmune and Inflammatory Disorders Research (5 papers), RNA Interference and Gene Delivery (4 papers) and Lysosomal Storage Disorders Research (4 papers). Shai Erlich is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (5 papers), RNA Interference and Gene Delivery (4 papers) and Lysosomal Storage Disorders Research (4 papers). Shai Erlich collaborates with scholars based in United States, Israel and Germany. Shai Erlich's co-authors include Edward H. Schuchman, Colin L. Stewart, Konrad Sandhoff, Charles L. Bisgaier, Daniel P. Perl, Kenichi Horinouchi, Robert J. Desnick, Klaus Ferlinz, James D. Thompson and Elena Feinstein and has published in prestigious journals such as Circulation, Nature Genetics and Blood.

In The Last Decade

Shai Erlich

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shai Erlich United States 13 840 297 140 126 116 16 1.2k
Akihiko Kudo Japan 25 715 0.9× 176 0.6× 61 0.4× 330 2.6× 96 0.8× 69 1.5k
Sherida E. Tollefsen United States 17 719 0.9× 138 0.5× 74 0.5× 98 0.8× 120 1.0× 29 1.3k
Ge-Hong Sun-Wada Japan 9 789 0.9× 106 0.4× 33 0.2× 42 0.3× 176 1.5× 9 1.2k
Joana Raquel Martins Germany 17 1.2k 1.4× 614 2.1× 44 0.3× 65 0.5× 163 1.4× 25 1.7k
Shun-Ai Li Japan 14 643 0.8× 147 0.5× 34 0.2× 242 1.9× 188 1.6× 17 1.0k
Stefanie Oess Germany 16 485 0.6× 296 1.0× 80 0.6× 29 0.2× 121 1.0× 32 1.1k
Sarmistha Mukherjee United States 19 501 0.6× 129 0.4× 90 0.6× 23 0.2× 46 0.4× 27 923
Barry S. Rosen United States 10 599 0.7× 397 1.3× 109 0.8× 47 0.4× 85 0.7× 10 1.4k
Tianqing Kong United States 16 492 0.6× 107 0.4× 306 2.2× 49 0.4× 55 0.5× 21 1.2k
Margaret E. Schelling United States 14 422 0.5× 154 0.5× 77 0.6× 25 0.2× 72 0.6× 28 944

Countries citing papers authored by Shai Erlich

Since Specialization
Citations

This map shows the geographic impact of Shai Erlich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shai Erlich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shai Erlich more than expected).

Fields of papers citing papers by Shai Erlich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shai Erlich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shai Erlich. The network helps show where Shai Erlich may publish in the future.

Co-authorship network of co-authors of Shai Erlich

This figure shows the co-authorship network connecting the top 25 collaborators of Shai Erlich. A scholar is included among the top collaborators of Shai Erlich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shai Erlich. Shai Erlich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Thielmann, Matthias, David Corteville, Gábor Szabó, et al.. (2021). Teprasiran, a Small Interfering RNA, for the Prevention of Acute Kidney Injury in High-Risk Patients Undergoing Cardiac Surgery: A Randomized Clinical Study. Circulation. 144(14). 1133–1144. 68 indexed citations
2.
Ailawadi, Gorav, Martin S. Polinsky, Dani Bitran, et al.. (2017). Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney Injury. Kidney International Reports. 2(5). 836–843. 29 indexed citations
3.
Ratner, Lee, Max D. Cooper, Shouhua Feng, et al.. (2014). Treatment with QPI-1002, a Short Interfering (SI) RNA for the Prophylaxis of Delayed Graft Function.. Transplantation. 98. 153–153. 12 indexed citations
4.
Antoszyk, Andrew N., Bradley J. Katz, Rishi P. Singh, et al.. (2013). A Phase I Open Label, Dose Escalation Trial Of QPI-1007 Delivered By A Single Intravitreal (IVT) Injection To Subjects With Low Visual Acuity And Acute Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). 54(15). 4575–4575. 8 indexed citations
5.
Thompson, James D., Douglas J. Kornbrust, Jeffrey W.-D. Foy, et al.. (2012). Toxicological and Pharmacokinetic Properties of Chemically Modified siRNAs Targeting p53 RNA Following Intravenous Administration. Nucleic Acid Therapeutics. 22(4). 255–264. 72 indexed citations
6.
Nguyen, Quan Dong, Ronald A. Schachar, Chudy I. Nduaka, et al.. (2012). Evaluation of the siRNA PF-04523655 versus Ranibizumab for the Treatment of Neovascular Age-related Macular Degeneration (MONET Study). Ophthalmology. 119(9). 1867–1873. 70 indexed citations
7.
Nguyen, Quan Dong, Ronald A. Schachar, Chudy I. Nduaka, et al.. (2012). Phase 1 dose-escalation study of a siRNA targeting the RTP801 gene in age-related macular degeneration patients. Eye. 26(8). 1099–1105. 61 indexed citations
8.
Nguyen, Quan Dong, Ronald A. Schachar, Chudy I. Nduaka, et al.. (2012). Dose-Ranging Evaluation of Intravitreal siRNA PF-04523655 for Diabetic Macular Edema (the DEGAS Study). Investigative Ophthalmology & Visual Science. 53(12). 7666–7666. 83 indexed citations
9.
Molitoris, Bruce A., Pierre C. Dagher, Ruben M. Sandoval, et al.. (2009). siRNA Targeted to p53 Attenuates Ischemic and Cisplatin-Induced Acute Kidney Injury. Journal of the American Society of Nephrology. 20(8). 1754–1764. 280 indexed citations
10.
Miranda, Sílvia R.P., Shai Erlich, Victor L. Friedrich, Shimon Gátt, & Edward H. Schuchman. (2000). Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann–Pick disease. Gene Therapy. 7(20). 1768–1776. 38 indexed citations
13.
Miranda, Sílvia R.P., Shai Erlich, Victor L. Friedrich, et al.. (1998). BIOCHEMICAL, PATHOLOGICAL, AND CLINICAL RESPONSE TO TRANSPLANTATION OF NORMAL BONE MARROW CELLS INTO ACID SPHINGOMYELINASE-DEFICIENT MICE1. Transplantation. 65(7). 884–892. 29 indexed citations
14.
Miranda, Sílvia R.P., Shai Erlich, Jan Visser, et al.. (1997). Bone Marrow Transplantation in Acid Sphingomyelinase-Deficient Mice: Engraftment and Cell Migration Into the Brain as a Function of Radiation, Age, and Phenotype. Blood. 90(1). 444–452. 31 indexed citations
16.
Horinouchi, Kenichi, Shai Erlich, Daniel P. Perl, et al.. (1995). Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease. Nature Genetics. 10(3). 288–293. 410 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026